Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. So I think that actually, to be honest, ...
Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns ...
Cyprus Mail on MSN
Sequoia zanubrutinib study: Long-term insights into BTK inhibition in treatment-naïve CLL/SLL
IntroductionBruton’s tyrosine kinase (BTK) is at the core of present day treatment in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) which in turn is redefining first line and ...
Experts evaluate the financial impact experience by patients receiving BTK inhibitor therapy. This is a video synopsis/summary of a Peer Exchange involving: Ryan Haumschild, PharmD, MS, MBA, CPEL; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results